CoChat
Cited by 14

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: A new role for phospholipids in the regulation of cardiac calcium cycling?

Hughes, Eleri, Clayton, Jonathan C., Middleton, David A. · 2009 · Biochimica et Biophysica Acta (BBA) - Biomembranes

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamem.2008.10.029

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 50

  1. Tada, 1983, Regulation of calcium transport by the ATPase-phospholamban system, J. Mol. Cell. Cardiol., 15, 565, 10.1016/0022-2828(83)90267-5 · doi:10.1016/0022-2828(83)90267-5
  2. Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
  3. Autry, 1997, Functional co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation, J. Biol. Chem., 272, 15872, 10.1074/jbc.272.25.15872 · DOI · Paper page
  4. Asahi, 2000, Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP, J. Biol. Chem., 275, 15034, 10.1074/jbc.275.20.15034 · DOI
  5. Sasaki, 1992, Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase, J. Biol. Chem., 267, 1674, 10.1016/S0021-9258(18)45998-4 · DOI · Paper page
  6. Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases — effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
  7. Hughes, 1996, An investigation of the mechanism of inhibition of the Ca2+-ATPase by phospholamban, Biochem. J., 318, 973, 10.1042/bj3180973 · DOI
  8. Waggoner, 2007, Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate, Biochemistry, 46, 1999, 10.1021/bi061365k · DOI
  9. Kimura, 1996, Phospholamban regulates the Ca2+-ATPase through intramembrane interactions, J. Biol. Chem., 271, 21726, 10.1074/jbc.271.36.21726 · DOI · Paper page
  10. Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI · Paper page
  11. Fujii, 1986, Characterization of structural unit of phospholamban by amino-acid sequencing and electrophoretic analysis, Biochem. Biophys. Res. Commun., 138, 1044, 10.1016/S0006-291X(86)80387-4 · doi:10.1016/s0006-291x(86)80387-4
  12. Toyofuku, 1993, Identification of regions in the Ca2+-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban, J. Biol. Chem., 268, 2809, 10.1016/S0021-9258(18)53845-X · DOI
  13. Toyofuku, 1994, Amino acids Glu(2) to Ile(18) in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-ATPase of sarcoplasmic reticulum, J. Biol. Chem., 269, 3088, 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
  14. Toyofuku, 1994, Amino acids Lys-Asp-Asp-Lys400 in the cardiac Ca2+-ATPase (SERCA2) are critical for functional association with phospholamban, Biophys. J., 66, A121
  15. Hughes, 1994, The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca2+-ATPase, Biochem. J., 303, 511, 10.1042/bj3030511 · DOI
  16. Sasaki, 1992, Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic-reticulum — effects of synthetic phospholamban peptides on Ca2+ pump Atpase, J. Biol. Chem., 267, 1674, 10.1016/S0021-9258(18)45998-4 · DOI · Paper page
  17. Reddy, 1995, Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca2+-Atpase, J. Biol. Chem., 270, 9390, 10.1074/jbc.270.16.9390 · DOI
  18. Jones, 1993, Residues 2–25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic-reticulum, J. Biol. Chem., 268, 11486, 10.1016/S0021-9258(19)50222-8 · doi:10.1016/s0021-9258(19)50222-8
  19. Lockwood, 2003, Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban, Biopolymers, 69, 283, 10.1002/bip.10365 · DOI · Paper page
  20. Starling, 1996, The effect of N-terminal acetylation on Ca2+-ATPase inhibition by phospholamban, Biochem. Biophys. Res. Commun., 226, 352, 10.1006/bbrc.1996.1360 · doi:10.1006/bbrc.1996.1360
  21. Hughes, 2007, Solid-state NMR and functional measurements indicate that the conserved tyrosine residues of sarcolipin are involved directly in the inhibition of SERCA1, J. Biol. Chem., 282, 10.1074/jbc.M611668200 · DOI · Paper page
  22. Zamoon, 2005, Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation, Proc. Natl. Acad. Sci. U. S. A., 102, 4747, 10.1073/pnas.0406039102 · DOI · Paper page
  23. Hughes, 2003, Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase, J. Biol. Chem., 278, 20835, 10.1074/jbc.M212208200 · DOI
  24. Kirby, 2004, Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase, Biochemistry, 43, 5842, 10.1021/bi035749b · DOI
  25. Clayton, 2005, The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces, Biochemistry, 44, 17016, 10.1021/bi0511383 · DOI
  26. Toyofuku, 1994, Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban, J. Biol. Chem., 269, 22929, 10.1016/S0021-9258(17)31597-1 · DOI
  27. East, 1982, Lipid selectivity of the Ca2+ and Mg2+ ion dependent adenosinetriphosphate studied with fluorescence quenching by a bromine phospholipid, Biochemistry, 21, 4144, 10.1021/bi00260a035 · DOI · Paper page
  28. Dalton, 1999, Anionic phospholipids decrease the rate of slippage on the Ca2+-ATPase of sarcoplasmic reticulum, Biochem. J., 342, 431, 10.1042/bj3420431 · doi:10.1042/bj3420431
  29. Levy, 1992, Reconstitution of the sarcoplasmic-reticulum Ca2+-Atpase — mechanisms of membrane–protein insertion into liposomes during reconstitution procedures involving the use of detergents, Biochimica. Biophys. Acta, 1107, 283, 10.1016/0005-2736(92)90415-I · DOI
  30. Hughes, 2003, Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase, J. Biol. Chem., 278, 20835, 10.1074/jbc.M212208200 · DOI
  31. Tatulian, 2002, The inhibitory action of phospholamban involves stabilization of a-helices within the Ca-ATPase, Biochemistry, 41, 741, 10.1021/bi011148d · doi:10.1021/bi011148d
  32. Klodos, 2002, Large-scale preparation of sodium–potassium ATPase from kidney outer medulla, Kidney Int., 62, 2097, 10.1046/j.1523-1755.2002.00654.x · DOI
  33. Esmann, 1988, ATPase and phosphatase activity of Na+, K+-ATPase: molar and specific activity, protein determination, Kidney Int., 156, 105
  34. Davis, 1976, Quadrupolar echo deuteron magnetic resonance spectroscopy in ordered hydrocarbon chains, Chem. Phys. Lett., 42, 390, 10.1016/0009-2614(76)80392-2 · DOI · Paper page
  35. Abraham, 2005, Isothermal titration calorimetry studies of the binding of a rationally designed analogue of the antimicrobial peptide gramicidin S to phospholipid bilayer membranes, Biochemistry, 44, 2103, 10.1021/bi048077d · DOI
  36. Oldenburg, 1996, Conformational studies on analogs of recombinant parathyroid hormone and their interactions with phospholipids, J. Biol. Chem., 271, 17582, 10.1016/S0021-9258(18)31372-3 · doi:10.1016/s0021-9258(18)31372-3
  37. Karim, 2001, Role of cysteine residues in structural stability and function of a transmembrane helix bundle, J. Biol. Chem., 276, 38814, 10.1074/jbc.M104006200 · DOI · Paper page
  38. Kholodenko, 2000, Why cytoplasmic signalling proteins should be recruited to cell membranes, Trends Cell. Biol., 10, 173, 10.1016/S0962-8924(00)01741-4 · DOI · Paper page
  39. Mascioni, 2002, Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban, J. Am. Chem. Soc., 124, 9392, 10.1021/ja026507m · DOI · Paper page
  40. Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl. Acad. Sci. U. S. A., 101, 14437, 10.1073/pnas.0402801101 · DOI · Paper page
  41. Andronesi, 2005, Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy, J. Am. Chem. Soc., 127, 12965, 10.1021/ja0530164 · DOI · Paper page
  42. Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
  43. Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U. S. A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
  44. Pikula, 1994, The relationship between phospholipid content and Ca2+-ATPase activity in the sarcoplasmic reticulum, Biochim. Biophys. Acta (BBA) - Biomembranes, 1196, 1, 10.1016/0005-2736(94)00198-7 · doi:10.1016/0005-2736(94)00198-7
  45. Takagi, 1971, Lipid composition of sarcoplasmic reticulum of human skeletal muscle, Biochim. Biophys. Acta (BBA) - Lipids Lipid. Metab., 248, 12, 10.1016/0005-2760(71)90069-5 · doi:10.1016/0005-2760(71)90069-5
  46. Gould, 1987, Effects of diet on the function of sarcoplasmic-reticulum, Biochem. J., 245, 751, 10.1042/bj2450751 · DOI
  47. Dalton, 1998, Interaction of phosphatidic acid and phosphatidylserine with the Ca2+-ATPase of sarcoplasmic reticulum and the mechanism of inhibition, Biochem. J., 329, 637, 10.1042/bj3290637 · doi:10.1042/bj3290637
  48. Oxenoid, 2005, The structure of phospholamban pentamer reveals a channel-like architecture in membranes, Proc. Natl. Acad. Sci. U. S. A., 102, 10870, 10.1073/pnas.0504920102 · DOI · Paper page
  49. Smith, 2001, Helical structure of phospholamban in membrane bilayers, J. Mol. Biol., 313, 1139, 10.1006/jmbi.2001.5101 · DOI
  50. Asahi, 2003, Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure, Trends Cardiovasc. Med., 13, 152, 10.1016/S1050-1738(03)00037-9 · DOI

Cited by

See all 14

Metadata

Authors
Hughes, E., Clayton, J. C., & Middleton, D. A.
Venue
Biochimica et Biophysica Acta (BBA) - Biomembranes
Publisher
Elsevier BV
Published
2009-02
Volume
1788
Issue
2
Pages
559-566
ISSN
0005-2736
Cited by
14
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.